Long-lasting CD8 + T cell responses are critical in combatting infections and tumors. The proinflammatory cytokine IFN-γ is a key effector molecule herein. We recently showed that in murine T cells, the production of IFN-γ is tightly regulated through AU-rich elements (AREs) that are located in the 3' Untranslated Region (UTR). Loss of AREs resulted in prolonged cytokine production in activated T cells and boosted anti-tumoral T cell responses. Here, we investigated whether these findings can be translated to primary human T cells. Utilizing CRISPR-Cas9 technology, we deleted the ARE region from the IFNG 3'UTR in peripheral blood-derived human T cells. Loss of AREs stabilized the IFNG mRNA in T cells and supported a higher proportion of sustained IFN-γ protein-producing T cells. Importantly, this was also true for tumor antigen-specific T cells. MART-1 TCR engineered T cells that were gene-edited for ARE-deletion showed increased percentages of IFN-γ producing MART-1specific ARE-Del T cells in response to MART-1 expressing tumor cells. Combined, our study reveals that ARE-mediated post-transcriptional regulation is highly conserved between murine and human T cells. Furthermore, generating antigen-specific ARE-Del T cells is feasible, a feature that could potentially be exploited for therapeutical purposes. elements. revealed that IFN- sensing is instrumental to protect the host from infections by Mycobacteria species [14]-[16]. IFN- also prevents the development of cancers. In fact, mice lacking the Ifng gene, or the signaling protein downstream of Ifngr1/2, Stat1, spontaneously develop tumors [17],[18]. Furthermore, a high IFNG-mediated gene signature correlates with clinical response rates to immunotherapy in humans [19],[20]. Conversely, copy number alterations of IFN- pathway genes correlates with poor response to immunotherapy [21]. The regulation of IFN- production is multi-layered. The IFNG locus is only demethylated in effector and memory T cells [22], allowing for locus accessibility and transcription upon T cell activation. While the production of T cell effector molecules has been mainly attributed to changes in transcription and the presence of transcription factors [23]-[27], recently, the role of post-transcriptional regulation in T cells has also become appreciated [28]-[33]. Posttranscriptional regulation is mediated by sequence elements and structures present in both the 5' and 3' untranslated regions (UTRs) of mRNA molecules [34]-[37] and nucleoside modifications, such as adenine methylation [38]. By facilitating the binding of RNA binding proteins (RBPs), microRNAs and long non-coding RNAs, these regulators combined determine the actual protein output of a cell [37]. One of these sequence elements are adenylate uridylate-rich elements (AREs). AREs are AUUUA pentamers present in multimers in the 3'UTR of mRNA molecules [39],[40]. Interestingly, many cytokine transcripts contain AREs [37],[39]. They function as binding hubs for RBPs and microRNAs [39]-[41]. Binding to AREs by these factors mediate mRNA MATERIALS AND METHODS Human PBMCs and cell culture Studies with human T cells from anonymized healthy donors were performed in accordance with the Declaration of Helsinki (Seventh Revision, 2013) after written informed consent (Sanquin). Peripheral blood mononuclear cells (PBMCs) were isolated through Lymphoprep density gradient separation (Stemcell Technologies). Cells were used after cryopreservation. Human T cells were cultured in T-cell mixed media (Miltenyi) supplemented with 5% heatinactivated human serum (Sanquin) and fetal bovine serum (FBS, Bodinco), 2mM L-glutamine, 20 IU/mL penicillin G sodium salts, 20 μg/mL streptomycin sulfate (all Sigma Aldrich), 100
INTRODUCTION
CD8 + T cells are critical for immunosurveillance and for the protection against invading pathogens. To do so, they produce effector molecules, including granzymes, chemokines, and cytokines. Interferon  (IFN-is a key cytokine for CD8 + T cells to exert their effector function [1] - [3] . IFN- is a pleiotropic cytokine that modulates angiogenesis, hematopoiesis, myelopoiesis and immune cell function [4] - [7] . During infections, IFN- can suppress the growth of pathogens through upregulation of antiviral factors [8] , and attract myeloid cells such as neutrophils to the site of infection [9] , [10] . Furthermore, IFN- sensing potentiates the innate immune response of dendritic cells, macrophages, monocytes and neutrophils to pathogens against (intra)cellular pathogens [9] - [13] . Indeed, point mutations and deletions in humans in the receptor for IFN-, IFNGR1 and IFNGR2, which often lead to premature stop codons, stability, localization and translation and thus fine-tunes the protein output [30] , [41] - [44] . By deleting the 3'UTR AREs from cytokine mRNA, the protein production is decoupled from ARE-mediated post-transcriptional regulation [30] , [43] , [45] . We recently showed that AREs present in the Ifng 3'UTR dampen anti-tumoral responses in a murine melanoma model [46] .
In fact, removal of AREs from the Ifng locus resulted in prolonged IFN- production in a tumor suppressive microenvironment, which translated into substantially delayed tumor outgrowth and prolonged survival [46] . The 3'UTR of IFN-is highly conserved between mice and men, in particular the region containing the AREs [30] . Therefore, we hypothesized that the regulation of IFN- production is also conserved. To unravel the post-transcriptional regulation of IFN- in primary human T cells, we removed a 160bp region by CRISPR-Cas9 technology from the IFNG 3'UTR locus that contained all AREs sequences. Similar to murine Ifng [46] , removal of AREs from the human IFNG locus (ARE-Del) results in increased IFN- production. Combining TCR gene transfer with ARE-deletion in primary human T cells confirmed increased IFN- production by ARE-Del T cells in response to tumor cells. The ARE-mediated regulation of IFN- is thus conserved in human T cells.
(Invitrogen) to produce Cas9 ribonuclear proteins (RNPs). Mixture was incubated at room temperature for at least 10min prior to nucleofection.
For nucleofection, 1*10 6 T cells/condition were harvested 72h after -CD3/-CD28 activation and transferred to DNA Lo-binding Eppendorf tubes (Eppendorf). Cells were washed once with PBS and supernatant was completely removed. Cells were resuspended in 20 L P2 Buffer (Lonza), Cas9 RNPs were added, and incubated for 2min. Cells were then electroporated in 16well strips in a 4D Nucleofector X unit (Lonza) with program EH-100. 100 L of pre-warmed complete medium was added and cells were allowed to recover for 5min in a humidified incubator at 37 ºC and 5% CO2. Cells were transferred to 48-well plates containing 500 L prewarmed complete medium and cultured in a humidified incubator at 37 ºC + 5% CO2.
CRISPR-mediated gene editing was tested on genomic DNA. Snapfrozen cell pellets (1*10 6 cells) were incubated overnight at 56 ºC while rotating at 850 RPM in 50 L lysis buffer (50 mM Tris-HCl, 2.5 mM EDTA, 50 mM KCl and 0.45% Tergitol at pH 8.0) that was freshly supplemented with 1 g/mL proteinase K (Roche). After deactivating proteinase K by incubating for 15min at 95 ºC, lysed cells were centrifuged for 10min at 13.000 RPM (20.000g).
Supernatant was transferred to a new tube. The IFNG genomic locus was amplified by PCR (30s at 98 ºC, (10s at 98 ºC, 30s at 65 ºC, 30s at 72 ºC) x40, 7min at 72 ºC, 2min at 15 ºC) with DreamTaq HotStart Green Polymerase (ThermoScientific) and primerpair IFNG_PCR_F and IFNG_PCR_R ( Table 1 ) and subsequently analyzed on 0.8% agarose gel. For Sanger sequencing, PCR product was purified with NucleoSpin Gel and PCR Clean-up kit (Macherey Nagel) according to manufacturer's protocol (Baseclear). ARE-deletion from IFNG mRNA was determined by total RNA extraction from snapfrozen pellets of 0.2*10 6 cells activated for 3h with -CD3/-CD28 activated T cells using Trizol (Invitrogen). DNA contamination was removed with RNA Clean & Concentrator 5 kit (Zymo Research) according to manufacturer's protocol. cDNA synthesis was performed in the presence or absence of SuperScript III Reverse Transcriptase according to manufacturer's protocol (Invitrogen). The resulting cDNA was amplified by PCR (30s at 98 ºC, (10s at 98 ºC, 30s at 62 ºC, 30s at 72 ºC)x40, 7min at 72 ºC, 2min at 15 ºC) with with DreamTaq HotStart Green Polymerase and primerpair IFNG_3'PCR_F and IFNG_3'PCR_R ( Table 1) and subsequently analyzed on a 2% agarose gel.
Generation of MART-1 TCR expressing T cells
PBMCs were activated for 72h with -CD3/-CD28, harvested, and transduced with MART-1 TCR retrovirus as previously described [49] . Briefly, non-tissue culture treated 24-well plates were coated with 50 µg/mL Retronectin (Takara) overnight at 4 °C and washed once with PBS.
Subsequently, 300 µL viral supernatant was added per well and was centrifuged for 1h at 4°C at 4000 rpm (2820g). 1*10 6 freshly activated T cells were added per well, spun for 10min at 1000 rpm (180g), and cultured at 37 °C and 5 % CO2 in a humidified incubator. After 24h, cells were harvested and cultured in T25 flasks at a concentration of 0.8*10 6 cells/mL for 3 days in complete medium.
Functional assays
T cells were stimulated with 1 g/mL pre-coated -CD3 and 1 g/mL soluble -CD28 for indicated time points. MART-1 TCR-transduced T cells were co-cultured with HLA-A*0201 + MART1 hi Mel 526 (MART1 + ), or HLA-A*0201 -MART1 lo Mel 888 (MART1 -) tumor cell lines [50] - [52] , in a 1:1 effector to target (E:T) ratio for indicated time points. 1 g/mL Brefeldin A (BD Biosciences) was added as indicated. Non-activated T cells were used as a negative control.
All stimulations were performed in T cell mixed medium supplemented with 10% FBS, 2mM L-glutamine, 20U/mL penicillin G sodium salts and 20μg/mL streptomycin sulfate. 
Flow cytometry and intracellular cytokine staining

Real-time PCR analysis
Total RNA was extracted using Trizol (Invitrogen). cDNA synthesis was performed with SuperScript III Reverse Transcriptase (Invitrogen), and real-time PCR was performed with SYBR green and a StepOne Plus RT-PCR system (both Applied Biosystems). Reactions were performed in duplicate or triplicate, and cycle threshold values were normalized to 18S levels.
Primer sequences for IFNG, TNF, and IL2 mRNA were previously described [47] .
To determine the half-life of IFNG mRNA, T cells were activated for 3 h with indicated stimuli, and then treated with 5 g/ml actinomycin D (ActD) (Sigma-Aldrich). Data were analyzed using StepOne Plus software (Applied Biosystems).
Statistical analysis
Results are expressed as mean ± SD when indicated. Statistical analysis between groups was performed with Prism (GraphPad Software, version 8), using paired or ratio paired Student's ttest when comparing 2 groups, or two-way ANOVA with Bonferroni's correction for multiple comparisons when comparing more than 2 groups. P values <0.05 were considered to be statistically significant.
RESULTS
Deletion of AREs from the IFNG locus by CRISPR-Cas9
The human IFNG 3'UTR contains 5 AU-rich elements (AREs), defined as AUUUA ( Figure   1A , underlined sequence). To remove all 5 ARE sequences within the 3'UTR of the IFNG locus, we designed 2 CRISPR guide RNAs (crRNAs) (Figure 1A , bold sequence). As a control, we included non-targeting crRNAs (control). PBMC-derived human primary T cells were activated with -CD3/-CD28 for 3 days prior to nucleofection with 30 g Cas9-RNP complexes (Figure 1B) . Using ATTO-labeled tracrRNA allowed us to follow nucleofection efficiency by flow cytometry. 3 days after nucleofection, virtually all CD8 + and CD4 + T cells were positive for ATTO550 (control 97,8± 0,9 %, ARE-Del 98,6 ± 0,4 %, Figure 1C, D) . In line with the described cleavage pattern of S. pyogenes Cas9 [53] , cleavage occurred between the 17 th and 18 th base of the designed crRNAs (Suppl Figure 2A) . The 160 bp deletion containing the AREs was efficient, as revealed by both PCR and by Sanger sequencing of the genomic IFNG 3'UTR region (Figure 1E; Suppl Figure 2A ). Importantly, nucleofection did not impact T cell survival (Figure 1D) , and ARE-Del nucleofected T cells expanded as efficiently as control nucleofected T cells, with a 9.2 ± 1.1 fold vs 8.9 ± 1.2 fold expansion within 8 days after removal from -CD3/-CD28.
To determine if gene editing affected the IFNG 3'UTR downstream of the ARE region, we extracted RNA from control and ARE-Del T cells. T cells were first activated for 3 h with -CD3/-CD28 to increase IFNG mRNA levels. After cDNA synthesis, we performed PCR from the IFNG mRNA coding region to the 3'end of the IFNG 3'UTR, resulting in a 509 bp fragment for the WT and a 349 bp fragment for the ARE-Del IFNG mRNA (Suppl Figure 2B) . The geneediting was thus specific for the ARE region and did not result in a premature transcriptional stop of the IFNG 3'UTR. In conclusion, ARE-deletion from the IFNG locus was efficient and specific in primary human T cells and did not impact T cell survival and expansion.
ARE-deletion stabilizes IFNG mRNA and augments protein production in human T cells
We next studied whether ARE-deletion from the IFNG locus altered IFNG mRNA levels. In T cells that were rested for 9 days after nucleofection, IFNG mRNA levels were approximately 2-fold higher in ARE-Del T cells compared to control T cells (Figure 2A) . In most donors, IFNG mRNA levels of ARE-Del T cells were also slightly increased upon 3h stimulation with -CD3/-CD28 compared to control T cells (Figure 2A) . TNFA and IL2 mRNA levels remained unaltered, indicating IFNG mRNA specific alterations in ARE-Del T cells (Suppl Figure 3A) . To determine IFNG mRNA half-life, T cells were treated with Actinomycin D, a drug that blocks de novo mRNA transcription. ARE-deletion significantly increased the stability of IFNG mRNA compared to control T cells (t1/2>2h compared to ~70min, Figure   2B ). This is similar to murine ARE-Del T cells [46] .
To determine whether ARE-deletion also modulated the IFN- protein production and/or kinetics, we activated ARE-Del and control T cells with -CD3/-CD28. To visualize the production kinetics, we added Brefeldin A for a maximum of the final 2h of stimulation [54] , and measured the production of IFN- protein via intracellular cytokine staining. In nonactivated T cells, we did not observe any protein production by any T cell type (Figure 2C) , indicating that like control T cells, ARE-Del T cells require T cell activation for cytokine production. Irrespective of the ARE-deletion, the production of IFN- by T cells peaks at 6h after stimulation (Figure 2C) , as previously described [3] , [47] . However, already from 2h of activation onwards, we found increased percentages of IFN--producing T cells in ARE-Del CD8 + T cells compared to control T cells (Figure 2C, D) . This increase in cytokine production was specific to IFN- and was not observed for TNF- or IL-2 (Suppl Figure 3B, C) . Even though we did not find overt differences in the IFN- production per cell (Figure 2D , bottom row), deletion of AREs promoted the IFN- production in both CD8 + and in CD4 + T cells ( Figure 2D , top row). Thus, ARE-deletion in the IFNG 3'UTR increases the stability of IFNG mRNA and augments the production of IFN-protein.
Prolonged cytokine production by human ARE-Del T cells upon removal of stimuli
We next questioned if ARE-deletion also modulates mRNA expression and protein production kinetics upon removal of stimulation. We therefore restimulated ARE-Del T cells and control T cells with -CD3/-CD28 for 72h, and transferred the cells to new wells to remove the stimulus. 24h after removal of the stimulus, WT T cells expressed slightly lower IFNG mRNA levels than ARE-Del T cells, which further dropped after 48h (Figure 3A) . In contrast, ARE-Del T cells maintained equally high IFNG mRNA levels for up to 72h (Figure 3A) .
Intriguingly, also the IFN- protein production was altered by ARE-deletion. Even though TNF- and IL-2 production was lost at 24h after removal from stimulation (Suppl Figure 3D) , ARE-Del CD8 + T cells retained their capacity to produce IFN- for up to 72h (Figure 3B, C) . This also translated in higher IFN- production per cell at 24h post antigen removal, as determined by the geoMFI of the IFN- producing T cells (Figure 3C) . This increased production is also observed in CD4 + ARE-Del T cells, albeit only for the first 24h (Figure 3C) . Together, these data show that, similar to murine T cells [30] , deletion of AREs from the IFNG 3' UTR results in prolonged IFN- production in human T cells.
TCR-engineered ARE-Del T cells are superior IFN- producers in response to tumor cells
IFN- mediated signaling is key for effective anti-tumoral T cell responses [55] . This prompted us to study whether ARE-Del T cells are also superior IFN- producers when encountering tumor cells. To this end, we combined ARE-deletion with TCR gene transfer. We first retrovirally transduced human CD8 + T cells with a codon-optimized MART-1 TCR that recognizes the HLA-A*0201 restricted epitope of MART-1 (aa26-35) [49] . After 5 days, MART-1 TCR engineered T cells were restimulated with -CD3/-CD28 for 72h prior to nucleofection. Of note, ARE-deletion was also highly efficient in TCR-engineered T cells (Suppl Figure 3E) . Furthermore, the combined TCR engineering with subsequent nucleofection did not affect the viability or the expansion capacity of ARE-Del versus control MART-1 TCR engineered T cells (92.3±2.3 vs 91.3±2.6 % live cells, and 12.9±5.2 vs 13.2±4.2 fold expansion within 7 days, respectively).
To study the production of IFN- in response to tumor cells, we exposed MART-1 TCRengineered ARE-Del T cells or control T cells to a MART-1 hi HLA-A*0201 + melanoma cell line (MART-1 + ) and to a MART-1 lo HLA-A*0201melanoma cell line (MART-1 -) [50]- [52] .
As expected, MART-1 TCR-engineered T cells only produce cytokines when co-cultured with MART-1 + tumor cells ( Figure 4A) . Interestingly, after 6h of co-culture with MART-1 + cells, a significantly higher percentage of MART-1 TCR-engineered ARE-Del CD8 + T cells produced IFN- than the control MART-1 TCR-engineered T cells (Figure 4A, B) . Again, the higher percentage of IFN- producing cells did not translate into significantly increased cytokine production per cell, as determined by the GeoMFI of the IFN- + T cells (Figure 4B) .
The increased percentage of IFN- producing cells in ARE-Del MART-1 TCR-engineered T cells compared to control T cells was also observed after 24h of co-culture (Figure 4B) . T cells were retransferred to freshly seeded tumor cells for another 24h and cytokine production was measured. At this time point, i.e. 48h of co-culture, no differences in cytokine production were observed (Figure 4B) . Overall, these finding show that the generation of antigen-specific ARE-Del T cells is feasible and allows to drive enhanced and prolonged IFN-production in response to target cells.
DISCUSSION
Here we show that the deletion of AREs from the IFNG 3'UTR in primary human T cells results in higher IFNG mRNA levels, enhanced numbers of IFN- producing T cells and prolonged IFN- production. These findings are in line with previous findings with murine ARE-Del T cells [43] , [46] . Thus, the highly conserved ARE region in the IFNG 3'UTR locus also provides conserved post-transcriptional regulation in T cells.
We also observed differences between murine and human ARE-Del T cells, which are primarily of quantitative nature. Murine ARE-Del T cells produce more IFN- per cell than wildtype T cells [46] . We did not observe this difference in human T cells. The overall mRNA stability in activated human control T cells is also lower than that of murine T cells. Whereas murine T cells show a t1/2 >2h upon antigen stimulation [30] , [33] , human control T cells activated with -CD3/-CD28 only reach a t1/2 ~ 70min. This also translates into lower overall IFN- protein output in human T cells, both in terms of responding T cells (60-80% in murine wild type T cells versus 30-50% in human T cells upon PMA-Ionomycin stimulation [47] , [54] ), and in terms of production kinetics. In fact, even though human and murine T cells initiate the IFN- production in the same time frame, human T cells cease to produce IFN- faster. To date, it remains unresolved whether these differences stem from different activation methods in murine and human T cells (MEF cells expressing antigen and B7.1 in murine [46] versus -CD3/-CD28 in human T cells), from different T cell responsiveness due to different requirements on nutrients and stimuli during culture conditions, from higher diversity in human CD8 + T cell populations [56] , or from intrinsic differences between murine and human T cells. Irrespective of the observed quantitative differences, we show here that ARE sequences are essential for the regulation of IFNG mRNA stability and IFN- protein output in both murine [46] and human T cells.
Excessive production of IFN- can induce immunopathology [57] - [65] . However, the AREs solely fine-tune post-transcriptional regulation of IFN- production, while leaving the requirement of antigen recognition and transcriptional regulation in murine and human T cells intact ( [46] , this study). Indeed, in studies with long term memory ARE-Del T cells in a Listeria infection and in a B16 melanoma model, we find the increased and prolonged IFN- production also only in the presence of tumor cells or after antigenic challenge [46] . We therefore anticipate only limited side effects of the ARE-deletion in T cells.
We here combined retroviral TCR engineering with efficient CRISPR-Cas9 mediated genome editing. This experimental setup is a powerful tool to study gene modification in human T cells in an antigen-specific setting. Furthermore, TCR engineering with CRISPR-Cas9 technology could also be useful for therapeutic purposes. It is noteworthy that upon CRISPR-Cas9 mediated genome editing, TCR-engineered T cells maintained their capacity to expand, a feature that is critical for generating large numbers of T cells required for cellular products. 
